Business Issues/Benchmarks

Grown Rogue Closes Initial Transactions to Enter New York

The Oregon-based cannabis company is planning to acquire PharmaCann’s New York license and assets.

New Mexico Cannabis Businesses Ask Judge to Halt New Track-and-Trace System

State licensees are seeking injunctive relief over New Mexico’s planned rollout of a replacement seed-to-sale system they say is not proven.

Aurora Cannabis Corrects Inaccurate Statements Made in Support of Curaleaf’s Hostile Bid

Aurora advised its shareholders to take no action regarding the Curaleaf offer at this time.

Vireo Growth Completes Acquisition of C21 Investments

The transaction expands Vireo’s Nevada footprint with three leading dispensaries and 104,000 square feet of cultivation and production capacity.

Michigan GOP Gubernatorial Nominee Plans to Repeal 24% Cannabis Tax, End Unregulated Hemp Sales

John James, who is vacating his seat as a U.S. congressman to run on the state’s Republican ticket for governor, outlined his cannabis reform policies.

DEA Judge Orders 294 Corrections to 2,500-Page Cannabis Hearing Transcript

The DEA’s administrative law judge said the fully corrected transcript for the cannabis rescheduling hearing will be made public no later than Aug. 26.

Aurora Cannabis Acquires Internode Pharma, HAP Pharma, Expanding Distribution Access to UK

The acquisitions further Aurora’s global medical cannabis growth.

Tilray Expands Cannabis Cultivation Capacity in Canada, Europe to Meet International Demand

The company expanded cultivation in Quebec and Portugal, increasing its total annual production capacity to approximately 275 metric tonnes.

55% of Massachusetts Voters Oppose Repealing Cannabis Laws

A majority of registered voters plan to reject a November ballot question that would backtrack the state’s adult-use legalization laws, according to a new poll.

Aurora Cannabis Urges Shareholders to Take No Action on Curaleaf’s Unsolicited Takeover Bid

The company claims Curaleaf’s hostile takeover bid is designed to pressure Aurora’s shareholders into a short-term decision for the benefit of Curaleaf shareholders.

US House Members Push Trump Administration for Guidance on Schedule III Federal Framework

A bipartisan quartet of lawmakers sent a letter to Trump and three cabinet members, asking for clarity on the federal policy for medical cannabis.

DEA Makes Final Schedule III Case, Tries to Discredit Nearly All Opposing Witnesses

The government’s final brief for the cannabis rescheduling hearing focuses on currently accepted medical use, a scientific and medical analysis, and the opposition’s ‘so-called experts.’

Page 1 of 552

Next Page